Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05721261 · ClinicalTrials.gov registry record · NA

Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation

A NA study of Nerve Injury, sponsored by Epineuron Technologies.

Recruiting
Registry status
NA
Development phase
110
Enrollment target
15
Study locations

NCT05721261 is a NA study of Nerve Injury that is actively recruiting participants, run by Epineuron Technologies. The registered enrollment target is 110 participants, above the 57-participant average among 7 other Nerve Injury trials with a reported enrollment target (93% higher). The trial reports 15 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05721261, a NA study of Nerve Injury, is actively recruiting participants, sponsored by Epineuron Technologies.

RECRUITING
Registry status
NA
Development phase
110 participants
Enrollment target
15
Study locations

Study Summary

A novel temporary peripheral nerve stimulation system that delivers a single dose of electrical stimulation therapy for 1 hour will be evaluated for safety and effectiveness.

Conditions Studied

Nerve Injury

Interventions

  • DEVICE Temporary Peripheral Nerve Stimulation System
  • DEVICE Sham Temporary Peripheral Nerve Stimulation System

Study Locations (15)

Ontario

  • Hamilton General Hospital - Hamilton
  • St. Joseph's Healthcare Hamilton - Hamilton
  • Roth | McFarlane Hand & Upper Limb Centre - London
  • Southlake Health - Newmarket
  • Humber River Health - Toronto
  • North York General Hospital - Toronto
  • Trillium Health Partners - Toronto

Florida

  • University of Florida Health - Gainesville
  • Orlando Health Jewett Orthopedic Institute - Orlando

Louisiana

  • Louisiana State University Health Sciences Center - New Orleans

Maryland

  • The Curtis National Hand Center - Baltimore

Pennsylvania

  • WellSpan Health - York

Texas

  • John Peter Smith Hospital - Fort Worth

Alberta

  • University of Alberta Hospital - Edmonton

New Brunswick

  • Saint John Regional Hospital - Saint John

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2023-08-11
Est. Completion 2026-09
Phase NA

Sponsor

Epineuron Technologies

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05721261

The ClinicalTrials.gov registry entry for NCT05721261 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 57-participant average among 7 other Nerve Injury trials with a reported enrollment target (93% higher). The listed sponsor is Epineuron Technologies, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nerve Injury appearing as the primary indexed condition, and to 2 interventions - of which Temporary Peripheral Nerve Stimulation System is the first listed.

NCT05721261 reports 15 study locations spanning 8 distinct geographic areas - top geographies include Ontario, Florida, Louisiana.

Frequently Asked Questions

What is clinical trial NCT05721261 about?

NCT05721261 is a clinical study titled "Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation". A novel temporary peripheral nerve stimulation system that delivers a single dose of electrical stimulation therapy for 1 hour will be evaluated for safety and effectiveness.

What is the current status of trial NCT05721261?

This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2023-08-11. Estimated completion is 2026-09.

What conditions does trial NCT05721261 study?

This clinical trial studies the following conditions: Nerve Injury.

What interventions are being tested in trial NCT05721261?

The interventions under investigation include: Temporary Peripheral Nerve Stimulation System (DEVICE), Sham Temporary Peripheral Nerve Stimulation System (DEVICE).

Who is sponsoring clinical trial NCT05721261?

This trial is sponsored by Epineuron Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05721261 being conducted?

This trial has 15 study locations across Florida, Louisiana, Maryland, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Nerve Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Nerve Injury

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.